Improvement of abnormal liver enzymes after rosiglitazone treatment in Chinese type 2 diabetes.
Zheng JQ, Wang K, Pei D, Chen YL, Chang YL, Hsu CH, Huang TM, Lin MY, Lin PY, Lin JD.
Zheng JQ, et al. Among authors: lin jd, lin py, lin my.
Indian J Pharmacol. 2012 May;44(3):372-6. doi: 10.4103/0253-7613.96340.
Indian J Pharmacol. 2012.
PMID: 22701249
Free PMC article.